Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: a nationwide cohort study of patients with type 2 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2021.101299 ◽

2021 ◽

pp. 101299

Author(s):

Jui Wang ◽

Hon-Yen Wu ◽

Kuo-Liong Chien

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Cardioprotective Effects

Download Full-text

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

Acta Diabetologica ◽

10.1007/s00592-014-0663-2 ◽

2014 ◽

Vol 51 (6) ◽

pp. 1015-1023 ◽

Author(s):

Seoyoung C. Kim ◽

Robert J. Glynn ◽

Jun Liu ◽

Brendan M. Everett ◽

Allison B. Goldfine

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Cardiovascular Events ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Differences in Cardiovascular and Renal Outcomes Between Sodium Glucose Co-Transporter-2 and Dipeptidyl Peptidase-4 Inhibitors Among Type 2 Diabetes Patients: A Real-World, Retrospective Cohort Study

SSRN Electronic Journal ◽

10.2139/ssrn.3759705 ◽

2021 ◽

Author(s):

Iskandar Idris ◽

Ruiqi Zhang ◽

Jil Billy Mamza ◽

Mike Ford ◽

Tamsin Morris ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study

Diabetes Therapy ◽

10.1007/s13300-018-0483-4 ◽

2018 ◽

Vol 9 (5) ◽

pp. 2133-2141 ◽

Author(s):

György Jermendy ◽

Zoltán Kiss ◽

György Rokszin ◽

Zsolt Abonyi-Tóth ◽

István Wittmann ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Antidiabetic Drugs ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Persistence To Treatment

Download Full-text

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13955 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1719-1727 ◽

Author(s):

Jong‐Mi Seong ◽

Jeong Yee ◽

Hye Sun Gwak

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

BMJ ◽

10.1136/bmj.k872 ◽

2018 ◽

pp. k872 ◽

Author(s):

Devin Abrahami ◽

Antonios Douros ◽

Hui Yin ◽

Oriana Hoi Yun Yu ◽

Christel Renoux ◽

...

Keyword(s):

Type 2 Diabetes ◽

Inflammatory Bowel Disease ◽

Cohort Study ◽

Bowel Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Inflammatory Bowel

Download Full-text

Dipeptidyl peptidase‐4 inhibitors and risk of diabetic retinopathy progression in patients with type 2 diabetes: a population‐based cohort study

Acta Ophthalmologica ◽

10.1111/aos.13972_74 ◽

2018 ◽

Vol 96 (S261) ◽

pp. 23-23

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.14142 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1925-1934

Author(s):

Mario Luca Morieri ◽

Benedetta Maria Bonora ◽

Enrico Longato ◽

Barbara Di Camilo ◽

Giovanni Sparacino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Comparison of cardiovascular and renal outcomes between sodium glucose co– transporter–2 and dipeptidyl peptidase–4 inhibitors among type 2 diabetes patients: a real–world, retrospective cohort study

10.1016/j.metabol.2020.154606 ◽

2021 ◽

Vol 116 ◽

pp. 154606

Author(s):

Iskandar Idris ◽

Ruiqi Zhang ◽

Jil Billy Mamza ◽

Mike Ford ◽

Tamsin Morris ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

Acta Diabetologica ◽

10.1007/s00592-020-01533-5 ◽

2020 ◽

Vol 57 (10) ◽

pp. 1181-1192

Author(s):

Yi-Chuan Chen ◽

Tien-Hsing Chen ◽

Chi-Chin Sun ◽

Jau-Yuan Chen ◽

Shy-Shin Chang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Diseases ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text